enrolling: trial is running, patient recruitment is underway approved: ethical approval has been received, patients not yet being recruited submitted: study awaiting [...]
We are delighted to announce that the first Newsletter of the TransBioLine project is online! This Newsletter summarizes the highlights of the scientific progress and the consortium activities during the first year of the project. Don’t [...]
The TransBioLine WP4 (Biomarkers of vascular injury) Letter of Intent was accepted by the FDA on February 2020 and the team is in preparation to discuss the FDA recommendations to [...]
TransBioLine Consortium met in Sitges, Barcelona, on the 30th September and 1st October 2019. Members of the 27 partners of the Consortium met in Sitges to report on progress during the first half year of [...]
From February 28th to March 1st 2019 participants from the 27 partners of the Consortium met during two full days to begin a new adventure. The meeting took place in Basel, Switzerland, in Novartis premises [...]
Innovative Medicines Initiative Launches Translational Safety Biomarker Pipeline Project […]
